(Q33801352)

29 July 2017

1 reference

title

Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis (English)

1 reference

29 July 2017

1 reference

Hayashi N

1 reference

29 July 2017

Mita E

series ordinal

1 reference

29 July 2017

publication date

1 September 1999

1 reference

Journal of Viral Hepatitis

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

357-365

1 reference

Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Cytotoxic T cells and viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Apoptosis by death factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Fas and other cell death signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Lethal effect of the anti-Fas antibody in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after Systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Delayed Fas-mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of TNF alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

The immune reactivity role of HCV-induced liver infiltrating lymphocytes in hepatocellular damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Role of Fas ligand in apoptosis induced by hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Human hepatocytes produce an isoform of FAS that inhibits apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Metalloproteinase-mediated release of human Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Downregulation of Fas ligand by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Hepatitis C virus core protein induces hepatic steatosis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Suppression of apoptotic cell death by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

The hepatitis B virus X gene induces p53-mediated programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Apoptosis as a mechanism of tissue injury in liver allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

Clinical, immunological, and pathological consequences of Fas-deficient conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1999.00175.X

10.1046/J.1365-2893.1999.00175.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference